We have encouraged people who received the #Covid19vaccine and healthcare professionals to report suspected side effects.

Out of nearly 1 billion vaccines administered, Eudravigilance received more than 1.7 million reports in the EU.

#EMAPresser

🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079807732580361

We placed extra obligations on the #Covid19vaccine makers.

They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022.

#EMAPresser

🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079498784366597

📢EMA's human medicines committee, the #CHMP, recommended 9⃣ new medicines for approval in the 🇪🇺, including:
☑️ one #COVID19vaccine
☑️ one medicine for #MultipleSclerosis
☑️ one medicine for #Epilepsy

➡️https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-march-2023

#PublicHealth

🐦🔗: https://n.respublicae.eu/EMA_News/status/1641782170711740416

RT @EMA_News
EMA recommends authorising HIPRA's #COVID19vaccine: Bimervax 💉, as a booster in people aged 16 and above.

🔗 For more info follow this link: https://ema.europa.eu/en/news/ema-recommends-approval-bimervax-covid-19-booster-vaccine

#COVID19 #Vaccination #UnitedInProtection

EMA recommends authorising HIPRA's #COVID19vaccine: Bimervax 💉, as a booster in people aged 16 and above.

🔗 For more info follow this link: https://ema.europa.eu/en/news/ema-recommends-approval-bimervax-covid-19-booster-vaccine

#COVID19 #Vaccination #UnitedInProtection

🐦🔗: https://n.respublicae.eu/EMA_News/status/1641455022063108099

Vaccines prevent the most serious consequences of COVID-19 & its variants.

Following @EMA_News' recommendation, we have now authorised Bimervax by HIPRA as the 8⃣th vaccine against COVID-19 in the EU.

#HealthUnion
RT @EMA_News: EMA recommends authorising HIPRA's #COVID19vaccine: Bimervax 💉, as a booster in people aged 16 and above.

🔗 For more info follow this link: https://www.ema.europa.eu:443/en/news/ema-recommends-approval-bimervax-covid-19-booster-vaccine

#COVID19 #Vaccination #UnitedInProtection

🐦🔗: https://n.respublicae.eu/EU_Health/status/1641480817795911681

La Agencia Europea del Medicamento @EMA_News recomienda la autorización la vacuna española 🇪🇸 de HIPRA, Bimervax, como refuerzo en mayores de 16 años.

🔗 Más información: https://ema.europa.eu/en/news/ema-recommends-approval-bimervax-covid-19-booster-vaccine

#COVID19 #Vaccination #UnitedInProtection
#COVID19vaccine
RT @EMA_News: EMA recommends authorising HIPRA's #COVID19vaccine: Bimervax 💉, as a booster in people aged 16 and above.

🔗 For more info follow this l…

🐦🔗: https://n.respublicae.eu/ComisionEuropea/status/1641455504601018368

❗️ EMA has started evaluating a marketing authorisation application for Bimervax, the #COVID19vaccine developed by HIPRA.

Check out our latest updates on the #COVID19 pandemic: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates

🐦🔗: https://n.respublicae.eu/EMA_News/status/1638470687554695168

The assessment of #COVID19Vaccine HIPRA 💉 is progressing, and we hope to conclude it very soon. #EMAPresser

🐦🔗: https://n.respublicae.eu/EMA_News/status/1625844808404049920

This working paper by Ronen Arbel Clalit Health Services, et. al. discusses the effectiveness of the Bivalent mRNA Vaccine in preventing severe COVID-19 outcomes:

Read more: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4314067

#COVID19Vaccine #preprint

Join the Royal Society of Canada and The Globe & Mail for this free webinar on December 8 > tgam.ca/Children. A panel of health care experts will answer your questions about #vaccination and #children’s #health through #COVID19 and beyond. #KidVaccine #COVID19Vaccine

Vaccines prevent the most serious consequences of COVID-19 & its variants

Following @EMA_News' recommendation, we have authorised the extended use of an adapted version of Comirnaty as a booster in children aged 5-11

➡https://europa.eu/!8r7CGq

#UnitedInProtection #HealthUnion
RT @EMA_News: The #CHMP recommended extending the use of an adapted version of #COVID19vaccine Comirnaty as a #booster in children aged 5 to 11.

🐦🔗: https://nitter.eu/EU_Health/status/1593287852153917441

RT @EMA_News: ‼️ EMA has recommended authorising the #COVID19vaccine Vidprevtyn developed by Sanofi Pasteur, for use as a booster in adults.

➕ 1⃣ 💉 🇪🇺

#PandemicResponse #HealthUnion #VaccinesWork

👉 https://www.ema.europa.eu/en/news/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine

🐦🔗: https://nitter.eu/eurireland/status/1591092175575842816

#InTodaysOJ : The #COVID19vaccine VidPrevtyn® Beta developed by Sanofi Pasteur has been approved by the #EuropeanUnion

👉https://europa.eu/!C3vHnH

#VaccinesWork #SafeVaccines #HealthUnion

🐦🔗: https://nitter.eu/EURLex/status/1590976625633824768

VidPrevtyn Beta is the latest #COVID19 vaccine to be authorized by the @EU_Commission, following @EMA_News' positive, scientific recommendation.

This gives 🇪🇺 countries another option for their vaccination strategies.

Get vaccinated: make vaccines work.
#UnitedInProtection
RT @EURLex: #InTodaysOJ : The #COVID19vaccine VidPrevtyn® Beta developed by Sanofi Pasteur has been approved by the #EuropeanUnion

👉https://eur-lex.europa.eu…

🐦🔗: https://nitter.eu/EU_Health/status/1591045497149853696

The #CHMP recommended extending the use of an adapted version of #COVID19vaccine Comirnaty as a #booster in children aged 5 to 11.

🐦🔗: https://nitter.eu/EMA_News/status/1591033105628164096

RT @EMA_News: ‼️ EMA has recommended authorising the #COVID19vaccine Vidprevtyn developed by Sanofi Pasteur, for use as a booster in adults.

➕ 1⃣ 💉 🇪🇺

#PandemicResponse #HealthUnion #VaccinesWork

👉 https://www.ema.europa.eu/en/news/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine

🐦🔗: https://nitter.eu/ECDC_EU/status/1590990878151409669

‼️ EMA has recommended authorising the #COVID19vaccine Vidprevtyn developed by Sanofi Pasteur, for use as a booster in adults.

➕ 1⃣ 💉 🇪🇺

#PandemicResponse #HealthUnion #VaccinesWork

👉 https://www.ema.europa.eu/en/news/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine

🐦🔗: https://nitter.eu/EMA_News/status/1590728893794684929

RT @EMA_News: EMA has published #ClinicalData supporting the possibility of administering Spikevax #Covid19vaccine together with a dose of #flu vaccine.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1589565141838082048

EMA has published #ClinicalData supporting the possibility of administering Spikevax #Covid19vaccine together with a dose of #flu vaccine.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1589557859884290048